Illinois Municipal Retirement Fund’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-84,016
Closed -$2.92M 1144
2025
Q4
$2.92M Sell
84,016
-710
-0.8% -$55.8K 0.04% 463
2025
Q3
$7.04M Sell
84,726
-958
-1% -$69.3K 0.09% 274
2025
Q2
$6.29M Buy
85,684
+34,040
+66% +$2.47M 0.09% 289
2025
Q1
$5.9M Buy
51,644
+4,117
+9% +$251K 0.09% 281
2024
Q4
$2.39M Buy
47,527
+368
+0.8% +$19.3K 0.03% 502
2024
Q3
$2.18M Buy
47,159
+1,498
+3% +$53.2K 0.03% 534
2024
Q2
$1.48M Sell
45,661
-6,799
-13% -$186K 0.02% 688
2024
Q1
$1.32M Buy
52,460
+2,608
+5% +$61.6K 0.02% 765
2023
Q4
$1.62M Sell
49,852
-3,724
-7% -$102K 0.03% 617
2023
Q3
$1.46M Buy
+53,576
New +$1.55M 0.03% 595

Other funds holding CORT

Illinois Municipal Retirement Fund's CORT Position: Q1 2026 in Review

Illinois Municipal Retirement Fund sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 84,016 shares — an estimated $2.92M sold.

Illinois Municipal Retirement Fund first reported a position in CORT in Q3 2023 and held it in 10 quarters. The position peaked at $7.04M in Q3 2025. 352 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Illinois Municipal Retirement Fund reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Illinois Municipal Retirement Fund sold 84,016 Corcept Therapeutics shares in Q1 2026, an estimated $2.92M.
  • Illinois Municipal Retirement Fund first reported a position in Corcept Therapeutics in Q3 2023 and held it in 10 quarters.
  • Illinois Municipal Retirement Fund's Corcept Therapeutics position peaked at $7.04M in Q3 2025.
  • 352 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Illinois Municipal Retirement Fund's 13F filing for Q1 2026, filed 5 May 2026.